CN104922472A - Traditional Chinese medicine formula for treating lung cancer - Google Patents
Traditional Chinese medicine formula for treating lung cancer Download PDFInfo
- Publication number
- CN104922472A CN104922472A CN201510307751.2A CN201510307751A CN104922472A CN 104922472 A CN104922472 A CN 104922472A CN 201510307751 A CN201510307751 A CN 201510307751A CN 104922472 A CN104922472 A CN 104922472A
- Authority
- CN
- China
- Prior art keywords
- parts
- lung cancer
- chinese medicine
- traditional chinese
- medicine formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine formula for treating lung cancer. The formula is characterized by comprising the following raw material components in parts by weight: 25-35 parts of dendrobe, 17-23 parts of the dried venom of toads, 12-18 parts of honeysuckle, 12-18 parts of scutellaria baicalensis, 9-13 parts of centipede, 9-13 parts of gecko and 5-12 parts of platycodon grandiflorum. The traditional Chinese medicine formula for treating lung cancer has a relatively good curative effect for treating advanced lung cancer, can directly and intensively take effect on cancer lesion, and has the efficacies of upholding the good, suppressing the bad, and improving the immunity of a human body.
Description
Technical field
The present invention relates to a kind of Chinese prescription being used for the treatment of pulmonary carcinoma.
Background technology
Herba Dendrobii is also known as Herba hedyotis costatae, and belonging to the orchid family Dendrobium, is a kind of Wild Medicinal of preciousness.Its effective ingredient is mainly dendrobium polysaccharide, dendrobine, aminoacid etc., and wherein dendrobium polysaccharide content is up to 21.7%, can significantly improve body's immunity, has nourishing the stomach and goes out the effect such as Tianjin, the kidney invigorating benefit power, nourishing YIN and clearing away heat, anoxia enduring, resisting fatigue, antitumor.Modern pharmacology research finds, Herba Dendrobii also has the effect of defying age and blood vessel dilating.
Shady and cool, the moistening environment of Herba Dendrobii happiness, to be often attached in High aititude overhanging cliff or woods in trunk and rock crevice.Because its medical value is high, growth conditions is special and distribution is limited to, and through long-term people for excavating, wild resource is deficient, and thus domestic market supply shortage, international market per kilogram dry product valency has reached more than 1000 dollars.
Because dendrobium officinale requires harsh to natural ecological condition, natural propagation rate is extremely low again, to such an extent as to the Herba Dendrobii with history in several thousand is endangered.As far back as eighties of last century the eighties, what Herba Dendrobii was just classified as focused protection by country treasures Endangered Medicinal Herb.In order to save Herba Dendrobii in imminent danger, allowing Herba Dendrobii better play a role in value, serving the numerous common people, country has put into effect corresponding policy in succession to various places government, and dendrobium officinale resource is given to legislative Protection, advocates artificial growth.Artificial growth Herba Dendrobii has prolifically all in the market, and larger has the ground such as Zhejiang, Yunnan, Guangxi, Guizhou, Hubei, Anhui.
Herba Dendrobii has very high medical value.Herba Dendrobii sweet in the mouth, light, micro-hardship, cold nature.Return stomach, lung, the heart, kidney channel.The hard matter profit of body.Herba Dendrobii nourishing YIN and clearing away heat, nourishing the stomach to promote the production of body fluid, nourishing the lung to arrest cough, tonifying kidney and improving eyesight.Cure mainly consumption of body fluid caused by febrile disease, deficiency-heat is not moved back, deficiency of stomach-Yin, and dry mouth and throat, gastralgia are retched, xeropulmonary cough, soreness of the waist and knees, and it is dark that the moon hinders order.This product is sweet cool clear and rich, main enter stomach kidney, during effect focuses on, lower two is burnt, both clearing away stomach-heat promoting the production of body fluid to quench thirst, and nourishing kidney-yin is brought down a fever improving eyesight again, for Tianjin wound is thirsty, the dark good medicine of deficiency of YIN order.
Summary of the invention
The technical problem to be solved in the present invention overcomes existing defect, provides a kind of Chinese prescription being used for the treatment of pulmonary carcinoma.
Object of the present invention carrys out specific implementation by the following technical programs:
Be used for the treatment of a Chinese prescription for pulmonary carcinoma, it is characterized in that: raw material components by weight: Herba Dendrobii 25-35 part, Venenum Bufonis 17-23 part, Flos Lonicerae 12-18 part, Radix Scutellariae 12-18 part, Scolopendra 9-13 part, Gekko Swinhonis 9-13 part, Radix Platycodonis 5-12 part.
Preferably, the above-mentioned Chinese prescription being used for the treatment of pulmonary carcinoma, raw material components by weight: Herba Dendrobii 30 parts, Venenum Bufonis 20 parts, Flos Lonicerae 15 parts, Radix Scutellariae 15 parts, Scolopendra 10 parts, Gekko Swinhonis 10 parts, Radix Platycodonis 7 parts.
By above usage ratio formula, medicine is ground into fine powder, incapsulates for subsequent use.
Beneficial effect of the present invention:
The present invention is used for the treatment of the Chinese prescription of pulmonary carcinoma, and treatment advanced lung cancer has good therapeutic effect, directly can concentrate and act on cancer, have upholding the good and suppress the bad simultaneously, improve the effect of body immunity.
Detailed description of the invention
Below the preferred embodiments of the present invention are described, should be appreciated that preferred embodiment described herein is only for instruction and explanation of the present invention, is not intended to limit the present invention.
embodiment 1:
Be used for the treatment of a Chinese prescription for pulmonary carcinoma, it is characterized in that: raw material components by weight: Herba Dendrobii 30 parts, Venenum Bufonis 20 parts, Flos Lonicerae 15 parts, Radix Scutellariae 15 parts, Scolopendra 10 parts, Gekko Swinhonis 10 parts, Radix Platycodonis 7 parts.
embodiment 2:
Be used for the treatment of a Chinese prescription for pulmonary carcinoma, it is characterized in that: raw material components by weight: Herba Dendrobii 25 parts, Venenum Bufonis 23 parts, Flos Lonicerae 12 parts, Radix Scutellariae 18 parts, Scolopendra 9 parts, Gekko Swinhonis 13 parts, Radix Platycodonis 5 parts.
embodiment 3:
Be used for the treatment of a Chinese prescription for pulmonary carcinoma, it is characterized in that: raw material components by weight: Herba Dendrobii 35 parts, Venenum Bufonis 17 parts, Flos Lonicerae 18 parts, Radix Scutellariae 12 parts, Scolopendra 13 parts, Gekko Swinhonis 9 parts, Radix Platycodonis 12 parts.
The foregoing is only the preferred embodiments of the present invention, be not limited to the present invention, although with reference to previous embodiment to invention has been detailed description, for a person skilled in the art, it still can be modified to the technical scheme described in foregoing embodiments, or carries out equivalent replacement to wherein portion of techniques feature.Within the spirit and principles in the present invention all, any amendment done, equivalent replacement, improvement etc., all should be included within protection scope of the present invention.
Claims (2)
1. be used for the treatment of a Chinese prescription for pulmonary carcinoma, it is characterized in that: raw material components by weight: Herba Dendrobii 25-35 part, Venenum Bufonis 17-23 part, Flos Lonicerae 12-18 part, Radix Scutellariae 12-18 part, Scolopendra 9-13 part, Gekko Swinhonis 9-13 part, Radix Platycodonis 5-12 part.
2. the Chinese prescription being used for the treatment of pulmonary carcinoma according to claim 1, is characterized in that: raw material components by weight: Herba Dendrobii 30 parts, Venenum Bufonis 20 parts, Flos Lonicerae 15 parts, Radix Scutellariae 15 parts, Scolopendra 10 parts, Gekko Swinhonis 10 parts, Radix Platycodonis 7 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510307751.2A CN104922472A (en) | 2015-06-08 | 2015-06-08 | Traditional Chinese medicine formula for treating lung cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510307751.2A CN104922472A (en) | 2015-06-08 | 2015-06-08 | Traditional Chinese medicine formula for treating lung cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104922472A true CN104922472A (en) | 2015-09-23 |
Family
ID=54110121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510307751.2A Pending CN104922472A (en) | 2015-06-08 | 2015-06-08 | Traditional Chinese medicine formula for treating lung cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104922472A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108815318A (en) * | 2018-09-20 | 2018-11-16 | 肖月华 | A kind of composition for immunological enhancement containing the lactobacillus and preparation method thereof and purposes |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1707238A1 (en) * | 2003-12-19 | 2006-10-04 | Ming Qi Oncology Chinese Medicines, Inc. | Pharmaceuticals of chinese traditional medicine of treating lung cancer and preparation method thereof |
| CN102526115A (en) * | 2007-10-28 | 2012-07-04 | 郭桂芹 | Medicament for treating and preventing immune diseases and cancers |
-
2015
- 2015-06-08 CN CN201510307751.2A patent/CN104922472A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1707238A1 (en) * | 2003-12-19 | 2006-10-04 | Ming Qi Oncology Chinese Medicines, Inc. | Pharmaceuticals of chinese traditional medicine of treating lung cancer and preparation method thereof |
| CN102526115A (en) * | 2007-10-28 | 2012-07-04 | 郭桂芹 | Medicament for treating and preventing immune diseases and cancers |
Non-Patent Citations (4)
| Title |
|---|
| 刘平等: "《昆虫巧治常见病》", 31 October 2014, 金盾出版社 * |
| 张民庆等: "《抗肿瘤中药的临床应用》", 30 September 1998, 人民卫生出版社 * |
| 李家春: "痰热清注射液治疗晚期肺癌合并肺部感染疗效观察", 《内蒙古中医药》 * |
| 金国梁等: "《防癌抗癌中药》", 31 August 2001, 上海科学技术出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108815318A (en) * | 2018-09-20 | 2018-11-16 | 肖月华 | A kind of composition for immunological enhancement containing the lactobacillus and preparation method thereof and purposes |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104173781A (en) | Traditional Chinese medicine composition capable of tonifying and replenishing lung qi, nourishing yin and moistening lung, and relieving asthma and suppressing cough, and preparation method thereof | |
| CN104922472A (en) | Traditional Chinese medicine formula for treating lung cancer | |
| CN103393944B (en) | Traditional Chinese medicine used for treating cough | |
| CN104840855A (en) | Traditional Chinese medicine composition for treating pulmonary tuberculosis | |
| CN104921201A (en) | Yin nourishing and lung clearing dendrobium nobile and lilium brownii soup | |
| CN105031490A (en) | Traditional Chinese medicine for treating anorexia and preparation method thereof | |
| CN104922473A (en) | Formula of compound traditional Chinese medicine comprising dendrobium officinale for children to clear away lung-heat | |
| CN102716224B (en) | Decoction formula for curing rhinitis and preparation method thereof | |
| CN105456739A (en) | Dendrobium nobile and chongcha tea liquor | |
| CN104800288A (en) | Traditional Chinese medicine for treating acute viral pharyngitis | |
| CN104606600A (en) | Traditional Chinese medicine composition for treating interstitial lung disease and preparation method of composition | |
| CN104056118A (en) | Traditional Chinese medicine decoction for treating pulmonary abscess | |
| CN103816436A (en) | Traditional Chinese medicine composition for treating downward flow of damp-heat | |
| CN104922474A (en) | Chinese herbal preparation for treating chloasma | |
| CN104922537A (en) | Traditional Chinese medicinal drink formula using dendrobium officinale as lead medicine | |
| CN104920716A (en) | Compound dendrobium liver-protecting tea | |
| CN104922536A (en) | Formula of traditional Chinese medicine tea comprising dendrobium officinale for nourishing stomach | |
| CN106215040A (en) | A kind of Chinese medicine composition treating asthma | |
| CN103768569B (en) | A kind of Chinese medicinal capsule for the treatment of chronic bronchitis | |
| CN104435779A (en) | Wind-expelling and collateral-dredging traditional Chinese medicine composition and preparation method thereof | |
| CN104383371A (en) | Traditional Chinese medicinal composition for treating pityriasis rosea | |
| CN102886023B (en) | Prescription for treating rheumatism bone pain | |
| CN104257952A (en) | Traditional Chinese medicine composition for treating chicken coccidiosis | |
| CN103550550B (en) | Traditional Chinese medicine for treating phlegm and blood stasis type gall disease | |
| CN103830576A (en) | Traditional Chinese medicine for treating chronic laryngitis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150923 |
|
| RJ01 | Rejection of invention patent application after publication |